Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a 177Lu radiopharmaceutical and local (intra-articular) therapy with a 188Re radiopharmaceutical-Reference-Cited by-同舟云学术

Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a 177Lu radiopharmaceutical and local (intra-articular) therapy with a 188Re radiopharmaceutical

Published:2022-10-25 Issue:4 Volume:12 Page:404-414
ISSN:2619-1172
Container-title:The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
language:
Short-container-title:Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya

Author:

Stepchenkova E. D.¹^ORCID,Tishchenko V. K.¹^ORCID,Vlasova O. P.²^ORCID,Petriev V. M.³^ORCID,Legkodimova N. S.¹^ORCID,Krylov V. V.¹^ORCID,Fedorova A. V.¹,Kuzenkova E. A.¹,Ostroukhoff A. A.¹,Shegai P. V.²^ORCID

Affiliation:

1. A. Tsyb Medical Radiological Research Centre of the National Medical Research Radiological Centre

2. A. Tsyb Medical Radiological Research Centre of the National Medical Research Radiological Centre; National Medical Research Radiological Centre

3. A. Tsyb Medical Radiological Research Centre of the National Medical Research Radiological Centre; National Research Nuclear University (MEPhI)

Publisher

SCEEMP

Reference19 articles.

1. Bernheim S. Radiumtherapy in tuberculosis and dioradin (radio-active mentholated iodine) as used in the treatment of tuberculosis. Vail-Ballou Co; 1911.

2. Knox R. Radiography and radio-therapeutics. London: A.&C. Black; 1917.

3. Gordon B. Radium in the treatment of lymphangioma of the tongue. Radium Quarterly. 1917;1(1):13–5.

4. Knapp FF, Dash A. Radiopharmaceuticals for therapy. Springer (India); 2016. https://doi.org/10.1007/978-81-322-2607-9

5. Mittra E, Bodei L. Landscape analysis of phase 2 and 3 clinical trials for targeted radionuclide therapy. J Nucl Med. 2021;62(8):1031–2. https://doi.org/10.2967/jnumed.120.258103